GlassScriptPhysician profile
Cecilia Chu
NPI 1396713814
$12,704.29
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $164 · 2021: $12K · 2022: $47.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,318.58 | 2019-2022 | |
| Allergan, INC. | $85.40 | 2019-2020 | |
| Abbvie INC. | $56.45 | 2020-2021 | |
| Avion Pharmaceuticals | $41.77 | 2021 | |
| Mayne Pharma Commercial LLC | $37.81 | 2021 | |
| Therapeuticsmd, INC. | $37.40 | 2019-2020 | |
| Trevena, INC. | $34.60 | 2021 | |
| Myovant Sciences INC. | $23.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.84 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.54 | 2019 | |
| Servier Pharmaceuticals LLC | $17.29 | 2019 | |
| Lupin INC. | $16.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.